Navigation Links
Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need
Date:7/10/2014

Ouagadougou, Burkina Faso (PRWEB) July 10, 2014

Women in the West African nation, Burkina Faso, today have access to an additional family planning option. Sayana® Press has the potential to increase access to contraception at all levels of the health system and in communities by combining a lower-dose formulation of a widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with the BD Uniject™ injection system.

Burkina Faso is the first of four African countries expected to begin introducing Sayana® Press in 2014, followed shortly by Niger. Senegal and Uganda also plan to introduce the contraceptive at the community level in select areas later this year.

“Family planning is vital if girls and women are to have voice, choice, and control in their lives,” said UK International Development Minister Lynne Featherstone. “Sayana® Press will help expand the contraceptive options available in developing countries, giving more girls and women the chance to make their own decisions about whether and when to have children.”

The introductions are being led by each country’s ministry of health and supported by a consortium of public and private partners that includes the UK’s Department for International Development (DFID), the US Agency for International Development (USAID), the United Nations Population Fund (UNFPA), Pfizer, PATH, and the Bill & Melinda Gates Foundation.

“Strong public-private partnerships are playing a critical role in expanding contraceptive access and options for women around the world,” said Chris Elias, President of Global Development at the Bill & Melinda Gates Foundation. “This innovative initiative brings us one step closer to ensuring that family planning is available to women when and where they want it.”

The launches follow the regulatory approval of Sayana® Press in each of the four introduction countries. In
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New In-Depth Report on Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2019
2. European Injectable Drug Delivery Report 2013: Market Forecasts to 2017
3. Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017
4. North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017
5. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
6. North American Injectable Drug Delivery Market worth $16.6 Billion by 2017
7. Mylan to Acquire Agila to Create Leading Global Injectables Platform
8. Using 3-D printing and injectable molds, bioengineered ears look and act like the real thing
9. New injectable hydrogel encourages regeneration and improves functionality after a heart attack
10. Contraceptives Market is Expected to Reach USD 23.3 Billion Globally in 2018: Transparency Market Research
11. HerKare Launched To Exclusively Treat Hormone Imbalance In Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Morton Grove, IL (PRWEB) , ... August 31, ... ... genotoxic impurities (PGIs), as a high priority in the drug development approval process. ... process. , This year, Regis Technologies, Inc., a Chicago-based CMO, has been ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Global & USA BioSimilar Market Analysis ... The highly awaited US Biosimilar market will be initiated ... biologic, Zarxio. How will the global market react? Will ... that biosimilars could save the US economy up to ...
(Date:8/28/2015)... Texas (PRWEB) , ... August 28, 2015 , ... ... Riordan, PhD and orthopedic surgeon, Wade McKenna, DO, announced today that the use ... Dallas, Texas, resulted in complete healing of an otherwise non-healing surgical knee wound. ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
Breaking Biology Technology:Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
... Results Improve for Year on Higher Services Revenues, ... Digirad Corporation,(Nasdaq: DRAD ), a leading provider ... offices, hospitals and imaging centers, today,reported narrower losses ... on,higher annual revenues and lower operating expenses for ...
... of Arizona optical scientists have broken a technological barrier ... and rewritten in a matter of minutes. , The ... are the first updatable three-dimensional displays with memory ... medical, industrial and military applications that require "situational awareness." ...
... 3.5 Billion Year-Old Genes Resurrected to Serve as Probes of Early Life ... ... Fla., and MENLO PARK, Calif., Feb. 6 ,Scientists at the Foundation for ... Park, CA) today publish,a study in the journal Nature where more than ...
Cached Biology Technology:Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 2Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 3Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 4Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 5Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 6Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 7UA optical scientists add new, practical dimension to holography 2UA optical scientists add new, practical dimension to holography 3Genes as Time Machines 2
(Date:8/11/2015)... 11, 2015 Today, ZUK announced its Android ... well as expected revenues in 2015 that relate to sales of ... guidance of approximately 2,200 MSEK for 2015. Jörgen Lantto, ... prominent smartphone manufacturer in China ... selected FPC1 155 for Z1 ...
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics ... of human interface solutions, today announced collaboration with ... on Windows 10. Microsoft leveraged Synaptics, deep expertise ... operating system. Through stringent testing, ... fully certified with Microsoft,s Precision TouchPad (PTP) specification ...
(Date:8/4/2015)... ALBANY, N.Y., Aug. 4, 2015  AMRI (NASDAQ: AMRI ) ... June 30, 2015. Highlights: , Second quarter ... increase from 2014 , Adjusted contract margins of ... EPS of $0.22, including a $0.05 decrease in EPS from royalties ... of $16 million "We are very pleased to ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... reduction of carbon dioxide emissions from coal-fueled power plants is ... The University of Texas at Austin as part of the ... of TXU Corp., will donate $1.8 million to the university ... research. The donation will cover a six-year program to improve ...
... under stress or injured, the adrenal gland releases cortisol ... the hormone's effects are many and varied, lowering the ... short-term exposure, while impairing learning if there's too much ... how cortisol is made is essential to producing medications ...
... Tissue engineering has emerged as a promising ... damaged organs and tissues, circumventing the complications ... to repair or regenerate damaged tissue by ... functionality during regeneration and eventually integrate into ...
Cached Biology News:Lower carbon dioxide emissions from coal-fueled power plants possible with technology development 2Lower carbon dioxide emissions from coal-fueled power plants possible with technology development 3Scientists unravel clue in cortisol production 2
Mouse monoclonal [M7-PB-E9] to pan alpha Sodium Potassium ATPase ( Abpromise for all tested applications)....
Transcription factor Sp2. [Source:Uniprot/SWISSPROT;Acc:Q02086] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
... Rabbit monoclonal [EP282Y] to Asparagine ... all tested applications). ... corresponding to residues in the ... Entrez GeneID: ...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Biology Products: